% | $
Quotes you view appear here for quick access.

Insmed Incorporated Message Board

  • stockerapproach stockerapproach Jun 19, 2013 10:05 AM Flag

    UBS started INSM at buy 6/18/2013 ...DowJones newswire.........Good luck people.

    FROM Etrade:

    Insmed Started at Buy by UBS INSM

    Jun 18, 2013 08:07:22 (ET)

    (END) Dow Jones Newswires

    June 18, 2013 08:07 ET (12:07 GMT)

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • From Seeking Alpha:

      11:27 AM UBS initiates Insmed (INSM +0.7%) at Buy with a $17.50 price target representing a 37% upside. Arikace "has a solid chance of success in its primary indication of cystic fibrosis," analyst Matthew Harrison says, adding that the "underappreciated" non-tuberculous mycobacteria opportunity could be another growth catalyst going forward. (Previous: Arikace's NTM indication possibly more compelling than CF opportunity) Read comments

      INSM price at time of publication: $12.87. Check INSM price now »

20.80-0.29(-1.38%)Mar 31 4:00 PMEDT